From April 1, 2023 to June 30, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 324,118 shares, representing 0.97% for KRW 2,997.54 million under the buyback announced on December 2, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,950 KRW | -3.09% | -4.49% | -32.23% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.23% | 144M | |
+18.77% | 125B | |
+14.05% | 108B | |
-7.16% | 23.64B | |
+2.77% | 22.39B | |
-11.93% | 17.78B | |
-41.74% | 16.43B | |
-13.47% | 16.34B | |
+2.23% | 13.56B | |
+27.13% | 11.59B |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.